AngioDynamics Inc. (NASDAQ:ANGO) reached a new 52-week high on Tuesday . The stock traded as high as $17.05 and last traded at $16.84, with a volume of 56,802 shares trading hands. The stock had previously closed at $16.83.

Separately, Zacks Investment Research raised shares of AngioDynamics from a “sell” rating to a “hold” rating in a research report on Monday, May 2nd. Five investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. AngioDynamics presently has an average rating of “Hold” and an average target price of $14.10.

The stock has a 50-day moving average of $16.06 and a 200-day moving average of $13.16. The firm’s market capitalization is $609.89 million.

AngioDynamics (NASDAQ:ANGO) last issued its quarterly earnings results on Wednesday, July 13th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.03. The business earned $93.40 million during the quarter, compared to analyst estimates of $88.64 million. The firm’s quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.14 earnings per share. On average, equities research analysts expect that AngioDynamics Inc. will post $0.63 EPS for the current fiscal year.

In other news, Director David F. Burgstahler sold 2,250,000 shares of the business’s stock in a transaction dated Friday, August 5th. The shares were sold at an average price of $14.62, for a total transaction of $32,895,000.00. Following the transaction, the director now directly owns 23,988 shares in the company, valued at approximately $350,704.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Avista Capital Partners Gp, Ll sold 2,241,000 shares of the business’s stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $14.62, for a total transaction of $32,763,420.00. The disclosure for this sale can be found here.

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease, and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.